Maturitas
Volume 71, Issue 2 , Pages 94-103, February 2012

Chronic kidney disease and diabetes

  • Ronald Pyram

      Affiliations

    • Division of Endocrinology SUNY Downstate Medical Center, 450 Clarkson Ave, Brooklyn, NY 11203, United States
    • Division of Endocrinology Brooklyn VA Medical Center, Brooklyn, NY, United States
  • ,
  • Abhishek Kansara

      Affiliations

    • Division of Endocrinology SUNY Downstate Medical Center, 450 Clarkson Ave, Brooklyn, NY 11203, United States
    • Division of Endocrinology Brooklyn VA Medical Center, Brooklyn, NY, United States
    • Kings County Hospital Center, Department of Medicine, 451 Clarkson Ave, Brooklyn, NY 11203, United States
  • ,
  • Mary Ann Banerji

      Affiliations

    • Division of Endocrinology SUNY Downstate Medical Center, 450 Clarkson Ave, Brooklyn, NY 11203, United States
    • Kings County Hospital Center, Department of Medicine, 451 Clarkson Ave, Brooklyn, NY 11203, United States
  • ,
  • Lisel Loney-Hutchinson

      Affiliations

    • Division of Endocrinology SUNY Downstate Medical Center, 450 Clarkson Ave, Brooklyn, NY 11203, United States
    • Kings County Hospital Center, Department of Medicine, 451 Clarkson Ave, Brooklyn, NY 11203, United States
    • Corresponding Author InformationCorresponding author at: Kings County Hospital Center, Department of Medicine, 451 Clarkson Ave, Brooklyn, NY 11203, United States. Tel.: +1 718 270 6324.

Received 28 October 2011; received in revised form 9 November 2011; accepted 9 November 2011. published online 18 November 2011.

Abstract 

Chronic kidney disease has a significant worldwide prevalence affecting 7.2% of the global adult population with the number dramatically increasing in the elderly. Although the causes are various, diabetes is the most common cause of CKD in the United States and an increasing cause of the same worldwide. Therefore, we chose to focus on diabetic chronic kidney disease in this review.

The pathogenesis is multifactorial involving adaptive hyperfiltration, advanced glycosylated end-product synthesis (AGES), prorenin, cytokines, nephrin expression and impaired podocyte-specific insulin signaling. Treatments focus on lifestyle interventions including control of hyperglycemia, hypertension and hyperlipidemia as well treatment of complications and preparation for renal replacement therapy. This review examines the current literature on the epidemiology, pathogenesis, complications and treatment of CKD as well as possible areas of future disease intervention.

Keywords: Chronic renal disease, Diabetes, Glomerular filtration rate, Nephropathy, Renal failure

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0378-5122(11)00394-X

doi:10.1016/j.maturitas.2011.11.009

Maturitas
Volume 71, Issue 2 , Pages 94-103, February 2012